Insulin Sensitivity and Secretion in Youth: From Normal to Diabetes
|
|
- Caitlin Tucker
- 6 years ago
- Views:
Transcription
1 Insulin Sensitivity and Secretion in Youth: From Normal to Diabetes Silva A. Arslanian MD Richard L. Day Professor of Pediatrics 1 year Jubilee, The Queen Silvia Children s Hospital Gothenburg, Sweden January 9, 213 Nesli Fida SoJung Rola Julia Tami Hala Ingrid Gungor Bacha Lee Saad Warren Hannon Tfayli Libman Sara Michaliszyn Lindsey George Javier de La Heras Elisa Andreatta Nancy Guerra Kristin Porter Sally Foster Resa Stauffer All the GCRC & PCTRC Nurses over the years
2 The Spectrum of Glucose Tolerance in Youth Years of Disease Progression??? Pre Pub OB-NGT OB-IFG/IGT T2DM T1DM The Spectrum of Glucose Tolerance in Youth Years of Disease Progression??? Pre Pub IR-NGT IR-IFG/IGT T2DM IS 3% -cell IS 55% lower -cell 2x high IS +/- -cell 5% lower IS 5% lower -cell 75% lower
3 Hyperinsulinemic-euglycemic clamp Plasma glucose Variable rate glucose IV insulin (4 or 8 mu/m 2 /min) Insulin Sensitivity Insulin Secretion Insulin Secretion High Low Low Insulin resistant subjects Insulin resistant with low -cell function DI = Sensitivity x secretion Insulin Sensitivity Insulin sensitive subjects High
4 Insulin Sensitivity Insulin Secretion Insulin Secretion High A B DI = Sensitivity x secretion Low Low AB Insulin Sensitivity High Insulin Sensitivity Insulin Secretion High Insulin Secretion BA Low Low B DI = Sensitivity x secretion A Insulin Sensitivity High
5 The Spectrum of Glucose Tolerance in Youth Years of Disease Progression??? Pre Pub OB-NGT OB-IFG/IGT T2DM IS 3% -cell IS 55% lower -cell 2x high IS +/- -cell 5% lower IS 5% lower -cell 75% lower Insulin Sensitivity, 1 st -Phase Insulin, DI & FI: Pre Puberty vs. Puberty Insulin Sensitivity (mg/min/kg FFM per ul/l) P< Pre Pub Puberty 1 st Phase Insulin ( u/ml) NS Pre Pub Puberty DI (mg/min/kg FFM) 2 1 P= Pre Pub Puberty Fasting Insulin ( u/ml) P= Pre Pub Puberty
6 Correlates of in vivo Insulin Sensitivity in Healthy Normal Weight Youth r P BMI BMI % % Body fat WC VAT The Spectrum of Glucose Tolerance in Youth Years of Disease Progression??? Pre Pub OB-NGT OB-IFG/IGT T2DM IS 3% -cell IS 55% lower -cell 2x high IS +/- -cell 5% lower IS 5% lower -cell 75% lower
7 Puberty & Insulin Resistance N Engl J Med 315: 215, 1986 J Pediatr 11: 481, 1987 J Clin Endocrinol Metab 72: 277, 1991 J Clin Endocrinol Metab 77: 725, 1993 Diabetes 43: 98, 1994 J Clin Endocrinol Metab 8: 172, 1995 Diabetes 48: 239, 1999 Pediatr Res 48: 384, 2 Int J Obesity 1: 1, 25 Pediatr Res 6: 1, 26 Hepatic Glucose Production Fasting Glucose Fasting Insulin 8 p = p =.23 ns 2 4 mg/dl 1 u/ml 1 Age Pre Post Pre Post Pre Post
8 Pediatr Res 6: 1, 26 Insulin Sensitivity Insulin Secretion DI p <.1 u/ml 2 1 p <.5 mg/kg/min ns Age Pre Post Pre Post Pre Post Pediatr Res 6: 1, 26 Adiponectin ( g/ml) 2 1 Pre Post Puberty Age Insulin sensitivity decreased by ~ 5% Insulin secretion doubled The decrease in insulin sensitivity was independent of changes in % BF Adiponectin decreased by ~5%
9 The Spectrum of Glucose Tolerance in Youth Years of Disease Progression??? Pre Pub OB-NGT OB-IFG/IGT T2DM IS 3% -cell IS 55% lower -cell 2x high IS +/- -cell 5% lower IS 5% lower -cell 75% lower Insulin Sensitivity in Normal-weight & Overweight Adolescents Bacha F et al. Diabetes Care 27: 547, 24 mg/min/kg FFM per u/ml 16 White Black P <.1 P <.1 NW OW NW OW BMI %BF
10 Insulin Sensitivity, 1 st -Phase Insulin, DI & FI: NW vs. Obese Adolescents Insulin Sensitivity (mg/min/kg FFM per ul/l) NW P<.1 53 OB 1 st Phase Insulin ( u/ml) P<.1 56 NW 56 OB DI (mg/min/kg FFM) 2 1 P< Fasting Insulin ( u/ml) 4 3 P< NW OB NW OB BMI, Insulin Sensitivity & Fasting Insulin Arslanian S & Danadian K: TEM 9(5): 194, 1998 Glucose Metabolism (mg/kg/min) r = -.74 p = BMI (kg/m 2 ) Fasting Insulin ( u/ml) Yellow: prepubertal, pink: pubertal r =.63 p = BMI (kg/m 2 )
11 The Spectrum of Glucose Tolerance in Youth Years of Disease Progression??? Pre Pub IR-NGT IR-IFG/IGT T2DM The role of abdominal adiposity Fat but metabolically fit youth Ethnicity differential in metabolic risk Android vs Gynoid Obesity Apple Pear Vague J: Presse Medicale 3: 339, 1947 Science 28: 1365, 1998
12 Abdominal Adipose Tissue (CT) Subcutaneous fat Lumbar L4-L5 Visceral fat Insulin Sensitivity in High vs Low-VAT Obese Adolescents Insulin Sensitivity (mg/kg/min per µu/ml) P=.32 High VAT Low VAT BMI 35.2 % BF 43.4 Bacha F et al J Clin Endocrinol Metab 88: 2534, 23
13 J Pediatr 148: 188, 26 Insulin sensitivity (mg/min/kg FFM per U/ml) Insulin Sensitivity and Fasting Insulin across Waist Circumference percentile Groups P <.1 <75 th 75-9 th >9 th <75 th 75-9 th >9 th Fasting insulin ( U/ml) WC % (Fernandez et al. J Pediatr 145: 439, 24) P <.1 WC % J Pediatr 149: 89, 26 Triglycerides (mg/dl) p<.1 HDL (mg/dl) <75 th 75-9 th <75 th 75-9 th WC% >9 categories th WC% categories >9 th p<.1
14 Childhood WC Predicts Adult Metabolic Syndrome Sun S et al. J Pediatr Sept. 27 Fels Data Waist Circumference (cm) th 95 Males 9 MS vs. Non-MS 75th th 25t th Age in Years
15 Abdominal obesity is used as the sine qua non for the diagnosis of metabolic syndrome in children and adolescents The Spectrum of Glucose Tolerance in Youth Years of Disease Progression??? Pre Pub IR-NGT IR-IFG/IGT T2DM The role of abdominal adiposity Fat but metabolically fit youth
16 Diabetes Care 29: 1599, 26 OB-MF OB-MUF P Age (yrs) ns BMI (Kg/m 2 ) ns % Body fat ns W/H ratio Visceral fat (cm 2 ) VO 2 max Adiponectin ( g/ml) HDL (mg/dl) pair-matched obese teens: OB-LR (MIR), OB-HR (SIR) Not all obese youth have the same risk despite similar BMI! Insulin Sensitivity (μmol/kg/min per pmol/l) OB-MF P<.1 OB-MUF 1 st Phase Insulin (pmol/l) P=.22 OB-MF OB-MUF DI (mmol/kg/min) P=.2 OB-MF OB-MUF Bacha et al Diabetes care 29:1599, 26
17 Conclusion Not all obese youth are the same! The Spectrum of Glucose Tolerance in Youth Years of Disease Progression??? Pre Pub IR-NGT IR-IFG/IGT T2DM What are the metabolic defects in Pre Diabetes? IGT IFG
18 Pediatr 116: 1122, 25 NHANES , n=915, >8 hr fasting Prevalence of youth IGT? IGT (%) T2DM (%) Quasi Population Based NHANES (99-2) (IFG:11)? STOPP-T2D 2 (IFG:4).4 Non Population Based Yale (4-1 yrs) 25 Yale (11-18 yrs) Pittsburgh 7 Pittsburgh 2 Italy Germany U.K..21
19 Diabetes Care 32: 1, 29 NGT IGT T2DM (8F + 4M) (13F + 6M) (1F + 7M) Age (yrs) 14.2 ± ± ±.3 BMI (Kg/m 2 ) 36. ± ± ± 1.3 % Body Fat 45.4 ± ± ± 1.7 WC 18.5 ± ± ± 2.9 VAT (cm 2 ) 75.8 ± ± ± 6.5 HbA1C (%) 5.2 ± ± ±.2* Insulin Sensitivity in NGT vs IGT vs T2DM Insulin-stimulated Rd (mg/kg/min) P<.5 NGT IGT T2DM
20 Insulin (pmol/l) NGT IGT T2DM Time (min) DI (mmol/kg/min) p<.1 NGT IGT T2DM Diabetes Care 32: 1, 29 2 hr glucose (mmol/l) 2 1 r=-.73 p<.1 NGT IGT T2DM DI (mmol/kg/min) 1
21 Conclusion IGT in youth is characterized by -cell dysfunction manifested in impaired 1 st -phase insulin secretion relative to insulin sensitivity, but preservation of 2 nd -phase insulin secretion. Youth with IGT are not more insulin resistant than their NGT peers if matched for body composition and fat topography. The Spectrum of Glucose Tolerance in Youth Years of Disease Progression??? Pre Pub IR-NGT IR-IFG/IGT T2DM What is the metabolic defect(s) in Pre Diabetes? IGT IFG
22 Diabetes Care: 33, 2225, 21 Insulin Sensitivity (μmol/min/kg FFM per pmol/l) p=.7 Insulin (pmol/l) NGT IFG IGT IFG+IGT T2DM 36 p<.1 p< NGT IFG IGT IFG/IGT T2DM Time (min) Diabetes Care: 33, 2225, 21 -cell Function relative to insulin sensitivity (mmol/min/kg FFM) p<.1 NGT IFG IGT IFG/IGT T2DM
23 Conclusion All pre diabetes states in obese youth, with similar BMI, % body fat and abdominal adiposity are characterized by reductions in -cell function relative to insulin sensitivity. IFG : greater impairment in both 1 st and 2 nd phase insulin secretion. IGT: impairment in 1 st phase insulin secretion. IFG /IGT: Intermediary phenotype Diabetes Care: 32, 1327, 29
24 Diabetes Care 34: 2597, 211 Diabetes Care 212
25 Diabetes Care 212 The Spectrum of Glucose Tolerance in Youth Years of Disease Progression??? Pre Pub IR-NGT IR-IFG/IGT T2DM What is the metabolic defect in T2DM?
26 Diabetes Care 28: 638, yrs old BMI: 4 HTN Study Subjects OBCN T2DM P Age (yrs) ns BMI (kg/m2) ns % Body fat ns VAT (cm 2 ) ns HbA1c (%) <.1 Gungor N et al. Diabetes Care 28: 638, 25
27 Insulin (pmol/l) T2DM OBC Time (min) p <.1 OBC T2DM DI (mg/kg/min) p <.1 OBC T2DM Gungor N et al. Diabetes Care 28: 638, 25 Adiponectin in youth T2DM 8 Adiponectin ( g/ml) p =.1 OBC T2DM Gungor N et al. Diabetes Care 28: 638, 25
28 Treatment Options for type 2 Diabetes in Adolescents and Youth 15 centers Funded by National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Designed in 22, ended 2/211, results April 212 Question What is the best treatment in preventing loss of glycemic control? Metformin Metformin + Intensive Lifestyle Metformin + Rosiglitazone
29 Primary Outcome Results Metformin + Rosi Metformin + Lifestyle Overall Failure rate 45.6% Metformin 319/699 Lancet June 25, 211
30 J Pediatr 144, 656, 24 9% decrease within 6 years 15% decline/year UKPDS 5% decline/year Pediatric Diabetes E Pub 212 After a median of 2 months -cell function declined 2% per year
31 The Spectrum of Glucose Tolerance in Youth Years of Disease Progression??? Pre Pub IR-NGT IR-IFG/IGT T2DM T1DM & Obesity
32 Diabetes Care 26: 2871, % Males Females < 11 yrs > 11 yrs Ab + Ab - From the 198s to the 199s the prevalence of overweight at diagnosis of type 1 diabetes has tripled Acta Pediatr 88: 1223, 1999 At age 18, girls with T1DM were 6.5 Kg heavier and had 2.7 kg/m 2 higher BMI than control girls. Diabetic Med 2: 15, 23 Abdominal fat accumulation was associated with Increased insulin requirements & hyperlipidemia
33 Can you tell what type of diabetes? Is it obese Type 1? Is it Type 2? 11 yrs old BMI: 4 HTN Large Ketonuria Type 1.5 diabetes Hybrid Diabetes Double Diabetes LADA LADY 8.1% ICA+, 3.3% GAD+, 34.8% IAA+ 5% requiring insulin after 1 year Pediatrics 17: e12, 21 J Pediatr Endocrinol Metab 15: 525, % + for one Ab, 1.8% + for GAD, or IA2 or both No difference in treatment related to AB + or - JCEM 89: 2222, 24 74% positive for any Ab, 32% + for 2 Abs, 11% + for 4 Abs
34 Ab + 36% Ab - Ab + Age (yrs) BMI z-scores C-Peptide (>1.5ng/dl) 33% 28% HbA1C (%) Glucose (mg/dl) Chol. (mg/dl) HDL (mg/dl) TG (mg/dl) Arch Dis Child 91: 473, 26 Can you tell what it is? Rooster Peacock
35 The Spectrum of Glucose Tolerance in Youth Years of Disease Progression??? Pre Pub IR-NGT IR-IFG/IGT T2DM What is the metabolic defect in T2DM? What are the metabolic features of Ab + T2DM? Diabetes 58: 738, 29 Ab- Ab+ OBCN P (6m+8f) (1m+14f) (23m+17f) (5B+9W) (12B+12W) (21B+19W) Age (yrs) ns BMI (kg/m2) ns HbA1c (%) <.1 DD (months) ns % Body Fat ns VAT (cm 2 ) ns
36 Insulin Stimulated Rd (mg/kg/min) Diabetes 58: 738, 29 P =.1 P =.3 Ab- Ab+ OBCN Insulin Stimulated Rd (mg/kg/min) P =.1 P =.3 Diabetes 58: 738, 29 Ab - Ab + OBCN NWCN
37 Insulin ( u/ml) Insulin Secretion OBCN Ab- Ab Time (min) mg/kg/min Disposition Index P =.1 Ab- Ab+ OBCN
38 HbA1c (%) r = -.64 p <.1 Ab+ Ab Disposition Index (IS X CF) (µmol/kg/min) Characteristics at Diagnosis Ab- Ab+ P Glucose (mg/dl) ns HbA1C (%) ns Ketones 18.8% 53.8%.2 Clinical Symptoms 65% 78.3% ns Insulin use 64.3% 7.8% ns FH of DM 92.9% 91.2% ns
39 Characteristics at the Present Ab- Ab+ P ALT (u/l) BP-Sys (mmhg) Insulin use 5% 58% ns Diabetes 58: 738, 29 - Ab negative clinically-diagnosed T2DM youth have the inherent/genetic insulin resistance typical of T2DM. - Ab positive CDx-T2DM youth with severe insulin deficiency are obese individuals with type 1 autoimmune diabetes.
40 The Spectrum of Glucose Tolerance in Youth Years of Disease Progression??? Pre Pub OB-NGT OB-IFG/IGT T2DM IS 3% -cell IS 55% lower -cell 2x high IS +/- -cell 5% lower IS 5% lower -cell 75% lower Thank You
41 Acknowledgement Satish Kalhan Allan Drash Jack Gerich David Kelley Dorothy Becker Chittiwat Suprasongsin Kapriel Danandian Vered Lewy Rola Saad Neslihan Gungor Fida Bacha Ingrid Libman So Jung Lee Hala Tfayli NIH (RO1, K24, MO1, UO1) Genentech Foundation Eli-Lilly & Comp. Richard L. Day endowed chair PCTRC Nurses All the volunteer children & their parents
NAFLD AND TYPE 2 DIABETES
NAFLD AND TYPE 2 DIABETES Sonia Caprio, MD STOPNASH Symposium on the Origin and Pathways of Nonalcoholic Steatohepatitis Washington 7, 215 Global Projection of Diabetes Hossain P et al. N Engl J Med 27;356:213
More informationType 2 Diabetes Mellitus in Adolescents PHIL ZEITLER MD, PHD SECTION OF ENDOCRINOLOGY DEPARTMENT OF PEDIATRICS UNIVERSITY OF COLORADO DENVER
Type 2 Diabetes Mellitus in Adolescents PHIL ZEITLER MD, PHD SECTION OF ENDOCRINOLOGY DEPARTMENT OF PEDIATRICS UNIVERSITY OF COLORADO DENVER Yes! Is Type 2 diabetes the same in kids as in adults? And No!
More informationType 2 Diabetes in Adolescents
Type 2 Diabetes in Adolescents Disclosures Paid consultant, Eli Lilly, Inc, Pediatric Type 2 Diabetes Clinical Trials Outline The burden of diabetes Treatment and Prevention Youth Diabetes Prevention Clinic
More informationThe changing face of diabetes in youth: lessons learned from studies of type 2 diabetes
Ann. N.Y. Acad. Sci. ISSN 0077-8923 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES Issue: The Year in Diabetes and Obesity The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes
More informationThe Changing Face of Diabetes in Youth: Lessons Learned from Studies of Type 2
Page of Annals of the New York Academy of Sciences 0 0 0 0 0 The Changing Face of Diabetes in Youth: Lessons Learned from Studies of Type Diabetes Tamara S. Hannon and Silva A. Arslanian Indiana University
More informationAbdominal adiposity as assessed by waist circumference (WC) is a significant predictor of cardiovascular disease and type
WAIST CIRCUMFERENCE IS AN INDEPENDENT PREDICTOR OF INSULIN RESISTANCE IN BLACK AND WHITE YOUTHS SOJUNG LEE, PHD, FIDA BACHA, MD, NESLIHAN GUNGOR, MD, AND SILVA A. ARSLANIAN, MD Objectives We examined how
More informationDiabetes Care 36: , 2013
Pathophysiology/Complications O R I G I N A L A R T I C L E Measuring b-cell Function Relative to Insulin Sensitivity in Youth Does the hyperglycemic clamp suffice? LINDSEY SJAARDA, PHD 1 SOJUNG LEE, PHD
More informationLaboratory analysis of the obese child recommendations and discussion. MacKenzi Hillard May 4, 2011
Laboratory analysis of the obese child recommendations and discussion MacKenzi Hillard May 4, 2011 aka: What to do with Fasting Labs The Obesity Epidemic The prevalence of obesity in adolescents has tripled
More informationMetabolic Syndrome in Asians
Metabolic Syndrome in Asians Alka Kanaya, MD Asst. Professor of Medicine, UCSF Asian CV Symposium, November 17, 2007 The Metabolic Syndrome Also known as: Syndrome X Insulin Resistance Syndrome The Deadly
More informationMetabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic
More informationDistinguishing T1D vs. T2D in Childhood: a case report for discussion
Distinguishing T1D vs. T2D in Childhood: a case report for discussion Alba Morales, MD Associate Professor of Pediatrics Division of Pediatric Endocrinology and Diabetes Disclosure I have no financial
More informationPREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS
PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS Mehmet Emre Atabek,MD,PhD Necmettin Erbakan University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and
More informationObesity, Metabolic Syndrome, and Diabetes: Making the Connections
Obesity, Metabolic Syndrome, and Diabetes: Making the Connections Alka M. Kanaya, M.D. Associate Professor of Medicine & Epi/Biostats University of California, San Francisco February 26, 21 Roadmap 1.
More informationTesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies
Tesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies Copyright 2016. All Rights Reserved. Property of Theratechnologies Inc. Mechanism of Action of Tesamorelin
More informationDeclining -Cell Function Relative to Insulin Sensitivity With Increasing Fasting Glucose Levels in the Nondiabetic Range in Children
Pathophysiology/Complications O R I G I N A L A R T I C L E Declining -Cell Function Relative to Insulin Sensitivity With Increasing Fasting Glucose Levels in the Nondiabetic Range in Children HALA TFAYLI,
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationPhenotypic Type 2 Diabetes in Obese Youth: Insulin Sensitivity and Secretion in Islet-cell Antibody Negative vs. Antibody Positive Patients.
Diabetes Publish Ahead of Print, published online December 10, 2008 Phenotypic Type 2 Diabetes in Obese Youth: Iulin Seitivity and Secretion in Islet-cell Antibody Negative vs. Antibody Positive Patients.
More informationRELATIONSHIP OF CLINICAL FACTORS WITH ADIPONECTIN AND LEPTIN IN CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES. Yuan Gu
RELATIONSHIP OF CLINICAL FACTORS WITH ADIPONECTIN AND LEPTIN IN CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES by Yuan Gu BE, Nanjing Institute of Technology, China, 2006 ME, University of Shanghai for
More informationPaul Hofman. Professor. Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland
Professor Paul Hofman Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland 9:25-9:50 Endocrine and Metabolic Consequences of Being Born Preterm
More informationMetabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology
Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient
More informationGestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014
Gestational Diabetes: Long Term Metabolic Consequences Gladys (Sandy) Ramos, MD Associate Clinical Professor Maternal Fetal Medicine Outline Population rates of obesity and T2DM Obesity and metabolic syndrome
More informationMETABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS
Rev. Med. Chir. Soc. Med. Nat., Iaşi 2012 vol. 116, no. 4 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS METABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS Ana-Maria Pelin 1, Silvia Mǎtǎsaru 2 University
More informationDiagnostic Test of Fat Location Indices and BMI for Detecting Markers of Metabolic Syndrome in Children
Diagnostic Test of Fat Location Indices and BMI for Detecting Markers of Metabolic Syndrome in Children Adegboye ARA; Andersen LB; Froberg K; Heitmann BL Postdoctoral researcher, Copenhagen, Denmark Research
More informationDistribution and Cutoff Points of Fasting Insulin in Asian Indian Adolescents and their Association with Metabolic Syndrome
Original Article Distribution and Cutoff Points of Fasting Insulin in Asian Indian Adolescents and their Association with Metabolic Syndrome NK Vikram*, A Misra**, RM Pandey***, Kalpana Luthra****, SP
More information2010 ADA Guidelines: 1. Diagnostic Criteria for DM 2. Categories of increased risk of DM. Gerti Tashko, M.D. DM Journal Club 1/21/2010
2010 ADA Guidelines: 1. Diagnostic Criteria for DM 2. Categories of increased risk of DM Gerti Tashko, M.D. DM Journal Club 1/21/2010 NEW: Diagnosis with A1c 6.5% Cut point of A1c 6.5% diagnoses 33% less
More informationNon-insulin treatment in Type 1 DM Sang Yong Kim
Non-insulin treatment in Type 1 DM Sang Yong Kim Chosun University Hospital Conflict of interest disclosure None Committee of Scientific Affairs Committee of Scientific Affairs Insulin therapy is the mainstay
More informationObjectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015
Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents
More informationCardiometabolic Side Effects of Risperidone in Children with Autism
Cardiometabolic Side Effects of Risperidone in Children with Autism Susan J. Boorin, MSN, PMHNP-BC PhD Candidate Yale School of Nursing 1 This speaker has no conflicts of interest to disclose. 2 Boorin
More informationYes! Is Type 2 diabetes the same in kids as in adults? And No! Youth-onset type 2 diabetes 5/16/2018 LEST WE THINK THIS IS NOT AN IMPORTANT PROBLEM
Youth-onset type 2 diabetes PHIL ZEITLER MD, PHD SECTION OF ENDOCRINOLOGY DEPARTMENT OF PEDIATRICS UNIVERSITY OF COLORADO DEPARTMENT OF ENDOCRINOLOGY CHILDREN S HOSPITAL COLORADO LEST WE THINK THIS IS
More informationPrevention of diabetes in the modern era of affluent society and economic constraints
Prevention of diabetes in the modern era of affluent society and economic constraints KONSTANTINOS MAKRILAKIS, MD, MPH, PhD ASSOCIATE PROFESSOR IN INTERNAL MEDICINE NATIONAL AND KAPODISTRIAN UNIVERSITY
More informationAECOM, Bronx, NY; 2 Incyte Corporation, Wilmington, DE; 3 dgd Research, San Antonio, TX; 4 Profil Institute, San Diego, CA
INCB013739, a Selective Inhibitor of 11β-Hydroxysteroid Dehydrogenase Type 1 (11βHSD1), Improves Insulin Sensitivity and Lowers Plasma Cholesterol Over 28 Days in Patients with Type 2 Diabetes Mellitus
More informationDiabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome
Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome John E. Nestler, M.D. William Branch Porter Professor of Medicine Chair, Department of Internal Medicine Virginia Commonwealth University
More informationThe Shape of the Glucose Response CurveDuringanOralGlucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth
Diabetes Care Volume 39, August 2016 1431 The Shape of the Glucose Response CurveDuringanOralGlucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth Joon Young Kim, 1 Sara F. Michaliszyn,
More informationRelationship to visceral adiposity, insulin sensitivity, and -cell function
Metabolic Syndrome/Insulin Resistance Syndrome/Pre-Diabetes O R I G I N A L A R T I C L E Adiponectin in Youth Relationship to visceral adiposity, insulin sensitivity, and -cell function FIDA BACHA, MD
More informationDiabetes Mellitus: Implications of New Clinical Trials and New Medications
Diabetes Mellitus: Implications of New Clinical Trials and New Medications Estimates of Diagnosed Diabetes in Adults, 2005 Alka M. Kanaya, MD Asst. Professor of Medicine UCSF, Primary Care CME October
More informationHypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents
Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of
More informationClinical Study Assessment of Metformin as an Additional Treatment to Therapeutic Lifestyle Changes in Pediatric Patients with Metabolic Syndrome
Cholesterol Volume 2012, Article ID 961410, 5 pages doi:10.1155/2012/961410 Clinical Study Assessment of Metformin as an Additional Treatment to Therapeutic Lifestyle Changes in Pediatric Patients with
More informationMetabolic Syndrome Across the Life Cycle - Adolescent. Joy Friedman MD
Metabolic Syndrome Across the Life Cycle - Adolescent Joy Friedman MD Disclosures I have no actual or potential conflict of interest in relation to this program or presentation. I will mention off-label
More informationIMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS
IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS Dr Bidhu Mohapatra, MBBS, MD, FRACP Consultant Physician Endocrinology and General Medicine Introduction 382 million people affected by diabetes
More informationJanice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES
Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Objectives u At conclusion of the lecture the participant will be able to: 1. Differentiate between the classifications of diabetes
More informationThe Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More informationImplementing Type 2 Diabetes Prevention Programmes
Implementing Type 2 Diabetes Prevention Programmes Jaakko Tuomilehto Department of Public Health University of Helsinki Helsinki, Finland FIN-D2D Survey 2004 Prevalence of previously diagnosed and screen-detected
More information3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.
U.S. Adults: 1988 Nineteen states with 10-14% 14% Prevalence of Obesity (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Metabolic John P. Cello, MD Professor of Medicine and Surgery, University of California,
More informationIs there an association between waist circumference and type 2 diabetes or impaired fasting glucose in US adolescents?
Is there an association between waist circumference and type 2 diabetes or impaired fasting glucose in US adolescents? Meghann M. Moore, RD, CD Masters Thesis Maternal & Child Health Track School of Public
More informationThe Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Update 2013 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine Denver Health
More informationDoes the oral glucose tolerance test distinguish between the two?
Pathophysiology/Complications O R I G I N A L A R T I C L E Islet Cell Antibody Positive Versus Negative Phenotypic Type 2 Diabetes in Youth Does the oral glucose tolerance test distinguish between the
More informationObesity, Weight Loss and Obstructive Sleep Apnea
Obesity, Weight Loss and Obstructive Sleep Apnea Gary D. Foster, Ph.D. Center for Obesity Research and Education Temple University School of Medicine Overview Sociocultural context Obesity: Prevalence
More informationDevelopment and Validation of a Method to Estimate Insulin Sensitivity in Patients With and Without Type 1 Diabetes
ORIGINAL ARTICLE Development and Validation of a Method to Estimate Insulin Sensitivity in Patients With and Without Type 1 Diabetes Lindsey M. Duca, David M. Maahs, Irene E. Schauer, Bryan C. Bergman,
More information3yr old WCC w/ pt Not Mykid
3yr old WCC w/ pt Not Mykid Obesity Webcast Department of Pediatrics, GCH@URMC New York State, Department of Health 2 16 yr old WCC, Last Yr Obesity w/ BMI Pt WLF 16 yr old w/ Cough. 3 4 Stigma of Child
More informationEnergy Balance Equation
Energy Balance Equation Intake Expenditure Hunger Satiety Nutrient Absorption Metabolic Rate Thermogenesis Activity Eat to Live! Live to Eat! EAT TO LIVE Intake = Expenditure Weight Stable LIVE TO EAT
More informationEndocrine Update Mary T. Korytkowski MD Division of Endocrinology University of Pittsburgh
Endocrine Update 2016 Mary T. Korytkowski MD Division of Endocrinology University of Pittsburgh Disclosure of Financial Relationships Mary Korytkowski MD Honoraria British Medical Journal Diabetes Research
More informationThe Diabetes Prevention Program: Call for Action
The Diabetes Prevention Program: Call for Action Osama Hamdy, MD, PhD, FACE Medical Director, Obesity Clinical Program, Director of Inpatient Diabetes Management, Joslin Diabetes Center Harvard Medical
More information5 Division of Pediatric Endocrinology, Metabolism and Diabetes Mellitus, Children s Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Page 1 of 25 1 Increased Lipolysis, Diminished Adipose Tissue Insulin Sensitivity and Impaired β-cell Function Relative to Adipose Tissue Insulin Sensitivity in Obese Youth with Impaired Glucose Tolerance
More informationAggressive Lipid Management for Diabetes
Aggressive Lipid Management for Diabetes Practical Ways to Achieve Targets in Diabetes Care Keystone, CO July 16, 2011 Robert H. Eckel, M.D. Professor of Medicine Professor of Physiology and Biophysics
More informationThe promise of the thiazolidinediones in the management of type 2 diabetes-associated cardiovascular disease
The promise of the thiazolidinediones in the management of type 2 diabetes-associated cardiovascular disease Steve Smith, Group Director Scientific Affairs, Diabetes & Metabolism GlaxoSmithKline R & D
More informationT2D risk phenotype after recent GDM. Supplemental Materials and Methods. Methodology of IVGTT/euglycemic hyperinsulinemic clamp
Supplemental Materials and Methods Methodology of IVGTT/euglycemic hyperinsulinemic clamp A combined IVGTT/euglycemic hyperinsulinemic clamp was performed in subgroups of study participants following the
More informationRoadmap. Diabetes and the Metabolic Syndrome in the Asian Population. Asian. subgroups 8.9. in U.S. (% of total
Diabetes and the Metabolic Syndrome in the Asian Population Alka Kanaya, MD Associate Professor of Medicine, UCSF Feb 26, 2010 Roadmap 1. Diabetes in Asian Americans Prevalence in the U.S. Risk factors
More informationCardiovascular Disease After Spinal Cord Injury: Achieving Best Practice. Suzanne Groah, MD, MSPH Walter Reed Army Medical Center February 12, 2010
Cardiovascular Disease After Spinal Cord Injury: Achieving Best Practice Suzanne Groah, MD, MSPH Walter Reed Army Medical Center February 12, 2010 CAVEAT LECTOR 2 CVD-related Mortality in Aging SCI GU
More informationSoo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital
Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital 1. Importance of Lowering LDL-Cholesterol in Diabetes Patients & Lipid Guidelines Prevalence of dyslipidemia in Korea Prevalence
More informationUniversità degli Studi di Chieti Clinica Pediatrica. M. Loredana Marcovecchio, Francesco Chiarelli
Università degli Studi di Chieti Clinica Pediatrica UP TO DATE SUL DIABETE M. Loredana Marcovecchio, Francesco Chiarelli Outline An update on T1D & T2D Epidemiology of diabetes Pathogenesis Treatment Complications
More informationDPP-4 inhibitor. The new class drug for Diabetes
DPP-4 inhibitor The new class drug for Diabetes 1 Cause of Death in Korea 1 st ; Neoplasm 2 nd ; Cardiovascular Disease 3 rd ; Cerebrovascular Disease Diabetes 2 Incidence of Fatal or Nonfatal MI During
More informationDiabetes and Obesity Sex- and Gender-differences!
Oskar Kokoschka 1908 Das Mädchen Li und ich Diabetes and Obesity Sex- and Gender-differences! Alexandra Kautzky Willer IGM, Berlin 2015 Global Diabetes-Epidemic Increase (%) in age-standardised diabetes
More information5/16/2018. Blake. Pediatric Case Studies. Blake
Pediatric Case Studies PHIL ZEITLER MD, PHD SECTION OF ENDOCRINOLOGY DEPARTMENT OF PEDIATRICS UNIVERSITY OF COLORADO DEPARTMENT OF ENDOCRINOLOGY CHILDREN S HOSPITAL COLORADO Blake 15 yo NHW male with long
More information3/25/2010. Age-adjusted incidence rates for coronary heart disease according to body mass index and waist circumference tertiles
Outline Relationships among Regional Adiposity, Physical Activity, and CVD Risk Factors: Preliminary Results from Two Epidemiologic Studies Molly Conroy, MD, MPH Obesity Journal Club February 18, 2010
More informationEpidemiology of Diabetes Mellitus in Asia
Epidemiology of Diabetes Mellitus in Asia Nam H. Cho Professor of Preventive Medicine Director of Clinical Epidemiology Ajou University School of Medicine and Hospital, Suwon Korea President-elect of International
More informationAtypical and Ketosis Prone Diabetes. Ashok Balasubramanyam, MD Baylor College of Medicine Houston, Texas
Atypical and Ketosis Prone Diabetes Ashok Balasubramanyam, MD Baylor College of Medicine Houston, Texas Atypical Diabetes in the Spectrum Classified as T1D Classified as T2D Auto-immune T1D T2D A- - KPD
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationMetabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine
Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine Setting the scene GB, 43 yo AA man followed for hypothyroidism returns on LT4 125 mcg/d and has a TSH=1.1
More informationIL METABOLISMO EPATICO DEI CARBOIDRATI IN FISIOLOGIA E PATOLOGIA
UNIGASTRO Il fegato come centrale metabolica e i fattori di danno oltre ai virus epatitici IL METABOLISMO EPATICO DEI CARBOIDRATI IN FISIOLOGIA E PATOLOGIA Dr Elisabetta Bugianesi Divisione di Gastro-Epatologia
More informationDiabetes Mellitus in the Pediatric Patient
Diabetes Mellitus in the Pediatric Patient William Bryant, M.D. Chief of Section Pediatric Endocrinology Children s Hospital at Scott & White Texas A&M University Temple, Texas Disclosures None Definitions
More informationEstablished Risk Factors for Coronary Heart Disease (CHD)
Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland
More informationUnderweight. Healthy Weight. At Risk of Overweight. Between 85 th and 95 th. Overweight 95 th CDC Website. BMI < 85th BMI >=85th BMI >=95th 83 75
Childhood Obesity & Motivational Interviewing Causes, Consequences and Current Management Strategies of Childhood Obesity Dana Rofey, PhD University of Pittsburgh School of Medicine Division of Weight
More informationOBESITY IN PRIMARY CARE
OBESITY IN PRIMARY CARE Obesity- definition Is a chronic disease In ICD 10 E66 Overweight and obesity are defined as abnormal or excessive fat accumulation that may impair health. Obesity is a leading
More informationSupplementary Online Content
Supplementary Online Content Anagnostou E, Aman MG, Handen BL, et al. Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autistic spectrum disorder:
More informationNicolucci C. (1), Rossi S. (2), Catapane M. (1), Introduction:
Bisphenol A and Nicolucci C. (1), Rossi S. (2), Catapane M. (1), (1) Dept. Experimental Medicine, Second University of (2) Institute of Genetic and Biophysics, CNR, Naples (3) Dept. of Pediatrics 'F. Fede',
More informationResearch Article The Relationship between Changes in Weight Status and Insulin Resistance in Youth
Hindawi Publishing Corporation International Journal of Pediatric Endocrinology Volume 2009, Article ID 862061, 7 pages doi:10.1155/2009/862061 Research Article The Relationship between Changes in Weight
More informationIschemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010
Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories
More information1/28/2014. The Metabolic Syndrome: Early History. Insulin Resistance: Early Diagnosis and Treatment to Prevent Cardiovascular Disease
: Early Diagnosis and Treatment to Prevent Cardiovascular Disease Henry N. Ginsberg, M.D. Irving Professor of Medicine Columbia University College of Physicans and Surgeons The Metabolic Syndrome: Early
More informationDiabetes Research Envisioned and Accomplished in Manitoba
Diabetes Research Envisioned and Accomplished in Manitoba Jonathan McGavock PhD Robert Wallace Cameron Chair in Evidence-based Child Health Department of Pediatrics and Child Health, Faculty of Medicine
More informationObesita e sindrome metabolica
Obesita e sindrome metabolica S. Bernasconi Dipartimento età evolutiva Clinica Pediatrica Università di Parma sbernasconi@ao.pr.it Obesita e sindrome metabolica 2500 PUBMED : 2000 Obesity 1500 Ultimo anno
More informationDiabetes Day for Primary Care Clinicians Advances in Diabetes Care
Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:
More informationDiabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE
Diabetes: Definition Pathophysiology Treatment Goals By Scott Magee, MD, FACE Disclosures No disclosures to report Definition of Diabetes Mellitus Diabetes Mellitus comprises a group of disorders characterized
More informationCase- history. Lab results
Neda Rasouli, M.D. Associate Professor of Medicine Division of Endocrinology, UC Denver VA_ Eastern Colorado Health Care System Case- history 46 y/o AA male with BMI 37 presented in Oct 2001 with polyuria,
More informationENDOTHELIAL PROGENITOR CELLS AS A NOVEL BIOMARKER OF VASCULAR HEALTH
ENDOTHELIAL PROGENITOR CELLS AS A NOVEL BIOMARKER OF VASCULAR HEALTH I Jialal, MD, PhD. FRCPath.DABCC Robert E. Stowell Chair in Experimental Pathology Professor of Pathology and Medicine Director, Laboratory
More informationCharacteristicsof Glucose Disposal Index in General Population in China
Characteristicsof Glucose Disposal Index in General Population in China QianRenM.D Department of Endocrinology and Metabolism, Peking University, People s Hospital Background We need to further characterize
More informationSupplementary Online Content
Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia
More informationTreatment guideline for adult patients with type 1 diabetes?
Treatment guideline for adult patients with type 1 diabetes? Jae Hyeon Kim Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine ICDM 2014 Treatment
More informationAddressing Addressing Challenges in Type 2 Challenges in Type 2 Diabetes Diabetes Speaker:
Addressing Challenges in Type 2 Diabetes Geneva Briggs, PharmD,, BCPS Addressing Challenges in Type 2 Diabetes Speaker: Dr. Geneva Clark Briggs, a board-certified Pharmacotherapy Specialist, received her
More informationCopyright 2017 by Sea Courses Inc.
Pre-Diabetes: Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any means graphic, electronic, or mechanical,
More informationWhy is Earlier and More Aggressive Treatment of T2 Diabetes Better?
Blood glucose (mmol/l) Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Disclosures Dr Kennedy has provided CME, been on advisory boards or received travel or conference support from:
More informationAssociation of serum adipose triglyceride lipase levels with obesity and diabetes
Association of serum adipose triglyceride lipase levels with obesity and diabetes L. Yang 1 *, S.J. Chen 1 *, G.Y. Yuan 1, L.B. Zhou 2, D. Wang 1, X.Z. Wang 1 and J.J. Chen 1 1 Department of Endocrinology,
More informationElevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with
Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance Mehrnoosh Shanaki, Ph.D. Assistant Professor of Clinical Biochemistry Shahid Beheshti
More informationHormonal Regulations Of Glucose Metabolism & DM
Hormonal Regulations Of Glucose Metabolism & DM What Hormones Regulate Metabolism? What Hormones Regulate Metabolism? Insulin Glucagon Thyroid hormones Cortisol Epinephrine Most regulation occurs in order
More informationPractical Approaches to Adolescents with Obesity and Metabolic Syndrome
Practical Approaches to Adolescents with Obesity and Metabolic Syndrome Dr Shirley Alexander Staff Specialist Paediatrician Children s Hospital at Westmead Head of Children s Hospital Institute of Sports
More informationLipids Carbohydrate Protein. Fatty Acids Glycerol. Mono/di-saccarides. Aminoacids. Fat Liver Muscle. Triglycerides Glycogen Protein
Lipids Carbohydrate Protein Fatty Acids Glycerol Mono/di-saccarides Fat Liver Muscle Aminoacids Triglycerides Glycogen Protein Microvascular Macrovascular Diabetes-specific Diabetes-enhanced HbA1c 5.7(6.0)
More informationAmerican Academy of Insurance Medicine
American Academy of Insurance Medicine October 2012 Dr. Alison Moy Liberty Mutual Dr. John Kirkpatrick Thrivent Financial for Lutherans 1 59 year old male, diagnosed with T2DM six months ago Nonsmoker
More informationDiabetes: Across the Lifespan Friday, October 17, Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children.
Diabetes: Across the Lifespan Friday, October 17, 2014 Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children. Don P. Wilson, M.D., FNLA Diplomate, Am Brd of Clinical Lipidology
More informationThe Diabetes Link to Heart Disease
The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM
More informationPrevention of complications: are we winning or losing the battle. Naveed Sattar Professor of Metabolic Medicine
Prevention of complications: are we winning or losing the battle Naveed Sattar Professor of Metabolic Medicine Duality of Interest Declaration Consultant or speaker for: Amgen, AstraZeneca, Boehringer
More informationPage 1. Disclosures. Background. No disclosures
Population-Based Lipid Screening in the Era of a Childhood Obesity Epidemic: The Importance of Non-HDL Cholesterol Assessment Brian W. McCrindle, Cedric Manlhiot, Don Gibson, Nita Chahal, Helen Wong, Karen
More information